• Users Online: 1400
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes

Thomas R, Parikh R, Muliyil J, George R, Paul P, Abraham Lekha M

Year : 2003| Volume: 51| Issue : 2 | Page no: 123-128

   This article has been cited by
1 Patient persistence with first-line antiglaucomatous monotherapy
Arias, A., Schargel, K., Ussa, F., Canut, M.I., Robles, A.B., Sánchez, B.M.
Clinical Ophthalmology. 2010; 4(1): 261-267
[Pubmed]  [Google Scholar]
2 Reporting of noninferiority and equivalence randomized trials for major prostaglandins: A systematic survey of the ophthalmology literature
Eyawo, O., Lee, C.-W., Rachlis, B., Mills, E.J.
Trials. 2008; 9(Art 69)
[Pubmed]  [Google Scholar]
3 Persistence and adherence with topical glaucoma therapy
Nordstrom, B.L., Friedman, D.S., Mozaffari, E., Quigley, H.A., Walker, A.M.
American Journal of Ophthalmology. 2005; 140(4): 598 e 1-598 e 11
[Pubmed]  [Google Scholar]
4 Latanoprost or brimonidine as treatment for elevated intraocular pressure: Multicenter trial in the United States
Camras, C.B., Sheu, W.-P.
Journal of Glaucoma. 2005; 14(2): 161-167
[Pubmed]  [Google Scholar]
5 Glaucoma management in developing countries: Medical, laser, and surgical options for glaucoma management in countries with limited resources
Thomas, R., Sekhar, G.C., Kumar, R.S.
Current Opinion in Ophthalmology. 2004; 15(2): 127-131
[Pubmed]  [Google Scholar]


Read this article